December 16, 2021
3 mins read

Needle-free air-powered Covid jab trial begins

The first volunteer will receive the vaccine this week at the NIHR Southampton Clinical Research Facility…reports Asian Lite News.

Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.

Developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax, the new DIOSvax technology is dubbed a next generation coronavirus vaccine administered through a blast of air that delivers the dose into the skin.

It offers a possible future alternative to people who fear needle-based jabs and, if successful, it could be scaled up and manufactured as a powder to boost global vaccination efforts, particularly in low and middle-income countries.

“The response of the scientific and medical communities to the development and delivery of COVID-19 vaccines has been incredible, but as new variants emerge and immunity begins to wane we need newer technologies,” said Heeney.

“It’s vital that we continue to develop new generation vaccine candidates ready to help keep us safe from the next virus threats. Our vaccine is innovative, both in terms of the way it primes the immune system to respond with a broader protective response to coronaviruses, and how it is delivered. Crucially, it is the first step towards a universal coronavirus vaccine we are developing, protecting us not just from COVID-19 variants but from future coronaviruses,” he said.

The first volunteer will receive the vaccine this week at the NIHR Southampton Clinical Research Facility.

The COVID-19 SARS-CoV-2 virus uses “spike” proteins on its surface to gain entry to host cells. These proteins bind to ACE2, a protein receptor on the surface of cells in our airways, allowing the virus to release its genetic material into the host cell. The virus hijacks the host cell’s machinery to allow itself to replicate and spread.

Vaccines inform our bodies about what dangerous infections look like and how to respond to them. This is much safer than becoming infected with the live virus, because it avoids the life-threatening effects the whole virus can have.

Immunisation arms our immune system to look out for and block virus, or destroy cells that carry the spike protein, protecting us from COVID-19 disease. Unfortunately, SARS-CoV-2 is constantly mutating and the virus spike protein itself is changing. This raises the prospect of “vaccine escape”, where changes to the spike protein mean the immune system is no longer able to recognise it.

To get around this problem, the Cambridge University team searched for new types of antigens — key regions of the virus — that are the same across coronaviruses that occur in nature, including in animals that carry them, such as bats.

While most COVID-19 vaccines use the sequence of the RNA for the virus spike protein from the first isolated samples of the COVID-19 virus in January 2020, the new DIOSvax technology uses predictive methods to encode antigens like the spike protein that mimic the wider family of coronavirus antigens, thus giving wider protection.

Professor Heeney explained: “DIOS-CoVax vaccines target elements of the virus structure that are common to all known ‘beta-coronaviruses’ – those coronaviruses that are the greatest disease threats to humans. These are structures that are vitally important to the virus life cycle, which means we can be confident that they are unlikely to change in the future.”

“These next generation DIOSvax vaccines should protect us against variants we’ve seen so far — alpha, beta, delta variants, for example — and hopefully future-proof us against emerging variants and potential coronavirus pandemics.”

Funding for the needle-free vaccine and trial was provided by Innovate UK, part of the UK Research and Innovation network.

ALSO READ-OMICRON: Why the rates are doubling every day?

Previous Story

Beijing controls influencers through state, non-state actors

Next Story

Taliban were invited to Kabul: Karzai

Latest from -Top News

Multi-alignment, upgraded

With US ties strained and China tense, New Delhi taps Europe’s harder edge for co-development, clean tech and strategic autonomy, writes Manoj Menon India is recalibrating its great-power hedging as frictions with

India-EU Trade Deal Breakthrough Soon?

Negotiators report increased momentum in discussions, which have been given a boost from US President Donald Trump’s tariff offensive…reports Asian Lite News India and the European Union aim to finalise a trade

Europe Seeks Peace in Gaza

European countries condemn Israeli interception of Gaza-bound flotilla, demand safety of citizens…reports Asian Lite News Israel’s interception of an international flotilla carrying humanitarian aid to Gaza has sparked condemnation across Europe, with

GAZA: Egypt to Host Peace Talks

Egypt hopes the discussions will help “end the war and the suffering of the brotherly Palestinian people, which has continued for two consecutive years…reports Asian Lite News Egypt will host Israeli and

‘My Injuries Made Me’

During his four-year battle with injury, the incumbent fast bowling spearhead made occasional appearances but couldn’t bear the workload and demands of red-ball cricket….reports Asian Lite News England tearaway Jofra Archer believes
Go toTop

Don't Miss

Six killed including gunman in Plymouth shooting

A third woman was taken to a local hospital, where

Food inflation peaking at UK supermarkets

Although the rate slightly decreased from 15.7% in the year